HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Bolli Selected Research

1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazene

11/2005Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS.
11/2004Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits.
4/2003Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Bolli Research Topics

Disease

59Myocardial Infarction
02/2022 - 08/2002
44Infarction (Infarctions)
10/2021 - 08/2002
28Ischemia
08/2015 - 03/2002
26Coronary Occlusion
03/2021 - 01/2002
24Heart Failure
02/2022 - 05/2005
21Reperfusion Injury
01/2019 - 08/2002
16Myocardial Ischemia (Ischemic Heart Diseases)
01/2019 - 02/2003
13Cardiomyopathies (Cardiomyopathy)
02/2022 - 08/2013
10Cicatrix (Scar)
02/2022 - 05/2007
10Left Ventricular Dysfunction
01/2021 - 06/2008
9Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 04/2003
6Fibrosis (Cirrhosis)
01/2019 - 01/2010
6Myocardial Stunning (Stunned Myocardium)
04/2003 - 01/2002
5Heart Diseases (Heart Disease)
05/2021 - 02/2016
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 11/2004
4Necrosis
05/2015 - 01/2003
4Hypertrophy
07/2014 - 05/2005
3Hypoxia (Hypoxemia)
12/2021 - 05/2005
3Cardiotoxicity
11/2020 - 01/2019
3Stroke (Strokes)
04/2017 - 01/2011
2Carcinogenesis
01/2022 - 08/2002
2Ventricular Remodeling
11/2021 - 04/2016
2Neoplasms (Cancer)
11/2020 - 01/2004
2Peripheral Arterial Disease
04/2017 - 09/2013
2ST Elevation Myocardial Infarction
01/2017 - 01/2017
2Inflammation (Inflammations)
07/2014 - 02/2006
2Hypercholesterolemia
10/2005 - 11/2004
1Infections
01/2022
1Cardiac Arrhythmias (Arrythmia)
01/2022

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
08/2015 - 01/2002
10Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2012 - 02/2003
7CytokinesIBA
06/2017 - 11/2004
6salicylhydroxamic acid (SHAM)IBA
10/2021 - 01/2002
6Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2014
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2019 - 11/2002
5Pharmaceutical PreparationsIBA
11/2020 - 02/2015
5cytidylyl-(3'-5')-cytidine (CpC)IBA
08/2016 - 03/2008
4CollagenIBA
02/2022 - 10/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2016 - 07/2004
3omega-Chloroacetophenone (Mace)IBA
01/2021 - 01/2018
3AldehydesIBA
01/2019 - 06/2008
3EnzymesIBA
01/2019 - 05/2005
3Oxygen (Dioxygen)IBA
01/2019 - 09/2013
3Acrolein (Aqualin)IBA
01/2019 - 06/2008
3Insulin (Novolin)FDA Link
07/2014 - 07/2008
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2013 - 07/2008
3Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2012 - 11/2004
3tricarbonylchloro(glycinato)ruthenium(II)IBA
01/2012 - 05/2004
3Caspase 3 (Caspase-3)IBA
01/2012 - 05/2005
3enhanced green fluorescent proteinIBA
06/2011 - 06/2008
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2009 - 04/2006
3HydrogenIBA
04/2008 - 01/2003
3SodiumIBA
04/2008 - 01/2003
3cariporideIBA
04/2008 - 01/2003
3Telomerase (Telomerase Reverse Transcriptase)IBA
03/2008 - 06/2005
3Nitric Oxide Synthase (NO Synthase)IBA
03/2008 - 04/2003
31- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA
11/2005 - 04/2003
3EndotoxinsIBA
05/2005 - 01/2002
3Opioid Analgesics (Opioids)IBA
01/2004 - 08/2002
3N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
01/2004 - 11/2002
2AnthracyclinesIBA
11/2020 - 01/2018
2Free RadicalsIBA
01/2019 - 08/2015
2Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
11/2018 - 05/2015
2Biological ProductsIBA
01/2017 - 09/2013
2Glucose (Dextrose)FDA LinkGeneric
06/2016 - 11/2008
2Trypan BlueFDA Link
05/2015 - 08/2007
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2013 - 07/2008
2Heme Oxygenase-1IBA
09/2012 - 11/2011
2erucylphosphocholineIBA
09/2012 - 11/2006
2ProstaglandinsIBA
01/2012 - 07/2004
2Transcription Factors (Transcription Factor)IBA
01/2012 - 07/2004
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2011 - 01/2006
2plerixaforFDA Link
10/2010 - 08/2007
2LigandsIBA
10/2009 - 04/2006
2diethylenetriamineIBA
11/2008 - 11/2004
2CalciumIBA
04/2008 - 01/2003
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2007 - 10/2005
2Celecoxib (Celebrex)FDA Link
10/2007 - 11/2002
2Phosphotransferases (Kinase)IBA
08/2007 - 10/2003
2Protein Kinase C-epsilonIBA
09/2005 - 03/2002
2InterleukinsIBA
05/2005 - 10/2004
2Saline SolutionIBA
05/2005 - 04/2004
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2004 - 08/2002
2Adenosine (Adenocard)FDA LinkGeneric
07/2004 - 08/2003
2Messenger RNA (mRNA)IBA
07/2004 - 01/2002
2NF-kappa B (NF-kB)IBA
07/2004 - 10/2003
2BW 373U86IBA
01/2004 - 11/2002
2Adenosine Triphosphate (ATP)IBA
12/2002 - 03/2002
1RNA (Ribonucleic Acid)IBA
01/2022
1CDC2 Protein Kinase (Protein p34cdc2)IBA
01/2022
1Cyclin-Dependent Kinase 4IBA
01/2022

Therapy/Procedure

28Therapeutics
01/2022 - 04/2003
23Cell- and Tissue-Based Therapy (Cell Therapy)
02/2022 - 08/2013
11Transplantation
01/2020 - 11/2005
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2012 - 01/2003
4Injections
01/2016 - 02/2006
3Intravenous Infusions
02/2022 - 04/2003
3Intraventricular Infusions
03/2021 - 01/2018
2Aftercare (After-Treatment)
01/2022 - 11/2002
1Intravenous Administration
02/2022